Stockhead4h
Crucible: This rare blood disease tackler plans to hit investors with its best shot
The myelofibrosis drug landscape has become more crowded since Syntara decided to focus on the disease in 2020, but the ...
Dr Boreham’s Crucible: This rare blood disease tackler aims to hit investors with its best shot
While the myelofibrosis drug landscape has become more crowded since Syntara (then Pharmaxis) decided to focus on that ...
UNITED STATES
All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.
Pharmaceutical Technology on MSN3d
Boehringer Ingelheim and Salipro enter drug discovery partnership
The partnership brings together Salipro’s tech for stabilising drug targets from Boehringer’s drug discovery programmes.
Salipro Biotech and Boehringer Ingelheim Enter Research and License Agreement to Accelerate Multiple Boehringer Ingelheim Pipeline Programs
Salipro Biotech AB, a Swedish biotech company specialising in the stabilisation of challenging drug targets, today announced a research and license agreement with Boehringer Ingelheim to accelerate ...
Contract Pharma4d
Boehringer Ingelheim Taps Salipro Biotech to Accelerate Pipeline Programs
Salipro Biotech has signed a research and license agreement with Boehringer Ingelheim to accelerate the development of ...
Key diabetes drug to cost up to 90% less in a few days
Indian drug companies are set to revolutionize diabetes treatment with affordable generic versions of Empagliflozin, ...
philstar.com18d
Specialized centers lead in Interstitial Lung Disease care: Here's what you need to know
Additionally, support from pharmaceutical partners like Boehringer Ingelheim has also enhanced the capacity of healthcare professionals to identify and manage ILD cases more effectively.
U.S. News & World Report19d
US Will Spend up to $1 Billion to Combat Bird Flu, USDA Secretary Says
(This story has been corrected to remove a reference to Boehringer Ingelheim receiving a vaccine license for turkeys in paragraph 10) (Reporting by Leah Douglas in Washington; additional reporting ...